Oncolytic Viral Therapy for Human Prostate Cancer by Conditionally Replicating Herpes Simplex Virus 1 Vector G207

Over the last few years, a conditionally replicating herpes simplex virus 1 (HSV‐1) vector, G207 has been used for the treatment of several malignant tumors. In this article we evaluate the antitumoral effect of G207 against prostate cancer in vitro and in vivo. The susceptibility of the human prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyama, Masafumi, Ohigashi, Takashi, Hoshi, Michio, Murai, Masaru, Uyemura, Keiichi, Yazaki, Takahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926297/
https://www.ncbi.nlm.nih.gov/pubmed/11123435
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00923.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926297/
https://www.ncbi.nlm.nih.gov/pubmed/11123435
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00923.x

Ejemplares similares